ISIN | CH0287280843 |
---|---|
Valor Number | 28728084 |
Bloomberg Global ID | |
Fund Name | Bellevue Healthcare Strategy I2 |
Fund Provider |
Bellevue Asset Management AG
Zürich, Switzerland Phone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Fund Provider | Bellevue Asset Management AG |
Representative in Switzerland | |
Distributor(s) |
Zürcher Kantonalbank Zürich Phone: +41 44 293 93 93 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | Special conditions apply to the issue of units |
Redemption Condition | Special conditions apply to the redemption of units |
Investment Strategy *** | N/A |
Peculiarities |
Current Price * | 151.43 CHF | 28.08.2025 |
---|---|---|
Previous Price * | 151.84 CHF | 27.08.2025 |
52 Week High * | 171.62 CHF | 30.01.2025 |
52 Week Low * | 142.35 CHF | 11.04.2025 |
NAV * | 151.43 CHF | 28.08.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 119,256,402 | |
Unit/Share Assets *** | 21,984,897 | |
Trading Information SIX |
YTD Performance | -6.46% |
31.12.2024 - 28.08.2025
31.12.2024 28.08.2025 |
---|---|---|
1 month | +0.75% |
28.07.2025 - 28.08.2025
28.07.2025 28.08.2025 |
3 months | +0.24% |
28.05.2025 - 28.08.2025
28.05.2025 28.08.2025 |
6 months | -8.46% |
28.02.2025 - 28.08.2025
28.02.2025 28.08.2025 |
1 year | -10.42% |
28.08.2024 - 28.08.2025
28.08.2024 28.08.2025 |
2 years | -4.48% |
28.08.2023 - 28.08.2025
28.08.2023 28.08.2025 |
3 years | -9.17% |
29.08.2022 - 28.08.2025
29.08.2022 28.08.2025 |
5 years | -4.66% |
28.08.2020 - 28.08.2025
28.08.2020 28.08.2025 |
Equity Participation Rate in % | 94.94 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 1.0191 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 28.08.2025 |
Thermo Fisher Scientific Inc | 3.49% | |
---|---|---|
Galderma Group AG Registered Shares | 3.35% | |
Vertex Pharmaceuticals Inc | 3.25% | |
AbbVie Inc | 3.22% | |
Eli Lilly and Co | 3.14% | |
Stryker Corp | 3.06% | |
Abbott Laboratories | 3.04% | |
Boston Scientific Corp | 3.03% | |
McKesson Corp | 3.01% | |
Sandoz Group AG Registered Shares | 2.95% | |
Last data update | 31.07.2025 |
TER | 0.61% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.60% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 31.07.2025 |